triiodothyronine has been researched along with Di Guglielmo Disease in 6 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of triiodothyronine (T3) on Na+,K(+)-ATPase activity of K562 human erythroleukemic cell was studied to understand why the erythrocyte sodium pump activity is decreased in hyperthyroidism." | 3.68 | Stimulation of the Na+,K(+)-ATPase activity of K562 human erythroleukemia cells by triiodothyronine. ( Arumanayagam, M; Swaminathan, R, 1992) |
| "We maintained human erythroleukemia K562 cells under hypoxic atmosphere (2% O₂) and examined their cellular characteristics." | 1.40 | Triiodothyronine suppresses activin-induced differentiation of erythroleukemia K562 cells under hypoxic conditions. ( Fujita, M; Kojima, I; Shiraishi, M; Tachibana, S; Tanaka, Y; Yamamoto, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, Y | 1 |
| Shiraishi, M | 1 |
| Fujita, M | 1 |
| Kojima, I | 1 |
| Tanaka, Y | 1 |
| Tachibana, S | 1 |
| Gauwerky, C | 1 |
| Golde, DW | 1 |
| Chiarugi, P | 1 |
| Raugei, G | 1 |
| Marzocchini, R | 1 |
| Fiaschi, T | 1 |
| Ciccarelli, C | 1 |
| Berti, A | 1 |
| Ramponi, G | 1 |
| Kikuchi, K | 1 |
| Yoshida, K | 2 |
| Endo, K | 1 |
| Aizawa, Y | 2 |
| Fukazawa, H | 2 |
| Mori, K | 2 |
| Abe, K | 1 |
| Hori, H | 1 |
| Kiso, Y | 1 |
| Sayama, N | 1 |
| Tani, JI | 1 |
| Ito, S | 1 |
| Arumanayagam, M | 1 |
| Swaminathan, R | 1 |
6 other studies available for triiodothyronine and Di Guglielmo Disease
| Article | Year |
|---|---|
Triiodothyronine suppresses activin-induced differentiation of erythroleukemia K562 cells under hypoxic conditions.
Topics: Activins; Cell Differentiation; Cell Hypoxia; Female; Humans; K562 Cells; Leukemia, Erythroblastic, | 2014 |
Hormonal effects on cell proliferation in a human erythroleukemia cell line (K562).
Topics: Butoxamine; Cell Division; Cell Line; Dexamethasone; Estriol; Fluoxymesterone; Hormones; Humans; Leu | 1980 |
Differential modulation of expression of the two acylphosphatase isoenzymes by thyroid hormone.
Topics: Acid Anhydride Hydrolases; Acylphosphatase; Amino Acid Sequence; Base Sequence; Blotting, Northern; | 1995 |
Effects of thyroid hormone on carbonic anhydrase I levels in human erythroid (YN-1) cells.
Topics: Carbonic Anhydrases; Erythrocytes; Hemoglobins; Humans; Kinetics; Leukemia, Erythroblastic, Acute; T | 1994 |
Effects of thyroid hormone on carbonic anhydrase I gene expression in human erythroid cells.
Topics: Carbonic Anhydrases; Erythroid Precursor Cells; Gene Expression; Humans; Leukemia, Erythroblastic, A | 1998 |
Stimulation of the Na+,K(+)-ATPase activity of K562 human erythroleukemia cells by triiodothyronine.
Topics: Cell Differentiation; Cytarabine; Erythrocytes; Erythroid Precursor Cells; Humans; Hyperthyroidism; | 1992 |